Home » Newsletters » BioWorld

BioWorld

Dec. 16, 1994

View Archived Issues

APPLIED IMMUNE SCIENCES BEGINS PHASE III OF EX VIVO CELL THERAPY FOR

OTHER NEWS TO NOTE

INDUSTRY APPLAUDS FASB DECISION TO DROP STOCK OPTION PROPOSAL

PROCYTE DOES NOT RESPOND TO SCHERER HEALTHCARE'S OFFER

MICE MISSING TNF RECEPTOR OFFER SEPSIS ANIMAL MODEL

TELIOS WITHDRAWS TENDER OFFER, CEO RESIGNS

DNA-MATCHING PINS AIDS-RELATED KAPOSI'S SARCOMA ON HERPESVIRUS

FBI FOILS BIOTECH INDUSTRIAL ESPIONAGE PLOT